Best GLP-1 programs when switching providers: routes for a clear handoff
Changing a GLP-1 provider should start with the actual existing prescription and last supply, not a promise to continue the same dose automatically. Concentration, f
Article updated
Read this firstArticle updated November 13, 2026; source dates below
Switching is a transfer of a treatment record, not simply a new checkout at the previous dose.
Previous clinician
Current treatment record
Preparation, prescribed amount, last administration and tolerability.
Receiving clinician
New assessment
Do not assume the old regimen transfers automatically.
Pharmacy
New label and device
Resolve differences in concentration or instructions.
Changing a GLP-1 provider should start with the actual existing prescription and last supply, not a promise to continue the same dose automatically. Concentration, formulation and pharmacy can differ. These seven routes show the questions needed to make a clinical handoff clearer.
Injection Index separates a lower bill from a safe transition. The receiving clinician should review treatment history, response and relevant health changes before selecting the next prescription. A matching ingredient name does not make two vials interchangeable or establish that the current regimen should continue unchanged.
Semaglutide $948/year ($79/mo equivalent) or $139 month-to-month; tirzepatide terms differ
Likeness Rx offers compounded semaglutide and tirzepatide with explicit term pricing. Its lowest advertised monthly equivalents are $79 and $129 on annual prepaid terms; month-to-month options cost more.
Trimi explicitly separates an annual monthly equivalent from the upfront bill: semaglutide is advertised at $1,188 for twelve months, with a different month-to-month rate.
The receiving clinician needs the current preparation, actual prescribed amount, last administration, tolerability and relevant treatment history. A branded pen and a compounded vial may not use the same concentration or device. Do not translate old syringe markings into a new preparation without professional instructions.
Coordinate the previous renewal and the new prescription decision to avoid assuming uninterrupted access. Ask when the former subscription stops, whether an order is already in pharmacy processing, and when the new team will complete its assessment.
Before you decide
Questions worth answering
Does the order on this page identify the best treatment for me?
No. It is a publisher-arranged comparison of selected public offers. The chart explains the specific purchase or evidence question; a licensed clinician must assess the actual treatment.
What should I verify for this comparison?
Switching is a transfer of a treatment record, not simply a new checkout at the previous dose. Ask for the selected written quote and the product-specific clinical explanation before making a purchase.
Evidence behind this page
Sources & chart notes
Source dates are listed with each document. Earlier research and later offer updates are identified separately. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.
Best GLP-1 programs when switching providers: routes for a clear handoff — keep the exact product identity and its complete label together.
What makes this shortlist useful
Prepare the existing label, prescribed instructions and information the clinician requests about use and response. Ask whether records can be reviewed and what happens before the next supply. Compare refill timing, payment and cancellation without overlapping orders on your own. The new prescriber and pharmacy should explain the actual concentration and instructions for any changed preparation. Read the related care guide for a wider treatment discussion.
What makes this shortlist useful — keep the exact product identity and its complete label together.
1. CoreAge Rx: a review of the prior prescription
CoreAge provides clinician assessment and a compounded injection pathway with a stated ingredient-specific starting rate. Its product pages separate semaglutide from tirzepatide. The prescription, concentration and amount dispensed should be confirmed rather than inferred from the price or transferred from another provider’s vial instructions. CoreAge’s current page explicitly directs a switching patient to discuss the previous prescription during intake. The clinician’s judgment determines the new plan; a monthly price or familiar ingredient should not be treated as automatic continuity of the same dose.
Ask why the actual compounded preparation is appropriate, which pharmacy will dispense it and what the complete labeled supply contains. Confirm the point at which a prepared order becomes non-refundable and who reviews the next prescription. For a handoff, ask how the new label and instructions differ from the existing supply.
SuperHealthy Rx advertises compounded semaglutide from $85/month and tirzepatide from $135/month. The linked offer says the provider visit and shipping are included. Confirm the amount due, plan term and refill settings; a prescription depends on clinician review. These are published service terms, not independently tested outcomes. Read the SuperHealthy Rx review.
SuperHealthy Rx: compare the selected agreement with the questions in this section.
3. Likeness Rx — GLP-1 weight care
Read the preparation and recurring invoice together. Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
The lowest monthly equivalents accompany 12-month subscriptions: $948 for semaglutide or $1,548 for tirzepatide. One-month plans are $139 and $199. The page says the selected term renews automatically; check the amount due and cancellation date.
The public site describes licensed-provider review, shipping after approval and care-team messaging. Those are service statements rather than measured response times.
These are provider-published terms checked October 4, 2026. Prescription approval is conditional. Compounded medications are not FDA-approved; we have not tested the treatment, pharmacy fulfillment or patient outcomes.
Product and subscription information checked at likenessrx.com on October 4, 2026.
4. Ro: an approved-product access discussion
Ro’s Body route separates a clinical membership from medication. The current page describes access to FDA-approved products, insurance support, provider messaging and care. That structure is useful to compare with medicine-inclusive bundles, while a membership floor alone does not identify the total treatment cost. Ro’s route may involve a different approved product and separate pharmacy bill. Ask how records and current treatment are reviewed, and obtain written instructions rather than assuming brand access preserves the exact prior preparation.
Ask for the selected membership term, full advance payment and separate pharmacy amount. Confirm which clinical access, insurance assistance and monitoring are included, and how the prescription and next payment change if the treatment plan is adjusted. For a handoff, ask how the new label and instructions differ from the existing supply.
Read the full Ro review to compare the care pathway, prescription and recurring order.
Ro: compare the selected agreement with the questions in this section.
5. Mochi Health: ongoing care with medication selection
Mochi combines provider access and nutrition-oriented support with a separate medication charge. Its current catalogue distinguishes branded medicines and compounded options. The exact selected medicine and diagnostics are outside the membership, so a product-card floor should not be mistaken for the complete monthly plan. Mochi’s provider access can be compared for a continuing relationship, while the selected branded or compounded medicine remains a separate decision. Confirm how the existing history is reviewed and what the first transferred supply costs.
Ask for the actual medicine and diagnostics quotation beside membership. Confirm availability in the patient’s state, who provides clinical and nutrition guidance and what the selected supply costs after any new-member access discount ends. For a handoff, ask how the new label and instructions differ from the existing supply.
Trimi describes individualized compounded semaglutide and tirzepatide prescriptions with provider review, supplies and shipment. It offers materially different annual and monthly payment commitments. The named pharmacy pathway helps identify what to ask, while regulatory status and clinical rationale still need separate consideration. Trimi’s current answers describe review of treatment history before a starting dose is chosen. That is different from guaranteed continuation. Check the monthly-versus-annual commitment after the clinical plan, not as the reason to transfer.
Ask whether the selected purchase is monthly or an annual commitment, how much is charged today and what can be refunded. Confirm the individualized pharmacy supply and clinical follow-up rather than treating the yearly equivalent as a monthly payment. For a handoff, ask how the new label and instructions differ from the existing supply.
Read the full Trimi review to compare the care pathway, prescription and recurring order.
7. Noom Med: a different care-and-support program
Noom Med links clinical care with an app and behavior-change resources. It has several distinct medication pathways, including standard compounded, microdose and branded-medication care. The plan name matters because included medicine and regular billing differ; engagement claims do not prove an individual result. A move to Noom may change the support model and medication pathway. Identify the exact plan and prescription rather than assuming a microdose, standard compounded and branded-care route are equivalent ways to continue the existing treatment.
Ask for the exact program name, full quarterly renewal and medicine inclusion. Confirm which coaching or app support is available and how care changes if the prescribed preparation is adjusted; a microdose promotion is not a standard-plan quote. For a handoff, ask how the new label and instructions differ from the existing supply.
Arrange the handoff around the clinician’s plan, not the lowest first charge or a shipping estimate. Keep the old and new labels and ask how the prescriptions relate. Canceling an account and changing treatment are separate actions, and prepared-order refund rules should be understood before the next payment.
Do not reuse a syringe conversion or dosing instruction from a different vial. Compounded preparations can have different concentrations, and the appropriate schedule is individualized. Resolve a delayed supply or uncertain transition with the clinician or pharmacist rather than combining leftover medication or guessing.
Original references are retained below. Later observations and their source dates are identified in the dated updates and research notes. Advertising describes an offer; it is not independent verification of treatment outcomes.